CORCEPT THERAPEUTICS INC (CORT) Forecast, Price Target & Analyst Ratings

NASDAQ:CORT • US2183521028

Current stock price

32.15 USD
-0.24 (-0.74%)
At close:
32.16 USD
+0.01 (+0.03%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CORCEPT THERAPEUTICS INC (CORT).

Forecast Snapshot

Consensus Price Target

Price Target
$85.68
+ 166.50% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$0.02
Revenue Estimate
196.36M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
75.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$85.68
Upside
+ 166.50%
From current price of $32.15 to mean target of $85.68, Based on 12 analyst forecasts
Low
$44.44
Median
$102.00
High
$127.05

Price Target Revisions

1 Month
-10.83%
3 Months
-37.88%

Price Target Summary

12 Wall Street analysts provided a forecast for the next 12 months for CORT. The average price target is 85.68 USD. This implies a price increase of 166.5% is expected in the next year compared to the current price of 32.15.
The average price target has been revised downward by 37.88% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CORT Current Analyst RatingCORT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

CORT Historical Analyst RatingsCORT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
75.00%
CORT was analyzed by 12 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about CORT.
In the previous month the buy percentage consensus was at a similar level.
CORT was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-25HC Wainwright & Co.Maintains Buy -> Buy
2026-02-20HC Wainwright & Co.Maintains Buy -> Buy
2026-01-23Canaccord GenuityMaintains Buy -> Buy
2026-01-23HC Wainwright & Co.Maintains Buy -> Buy
2026-01-02Canaccord GenuityMaintains Buy -> Buy
2026-01-02HC Wainwright & Co.Maintains Buy -> Buy
2025-12-16UBSInitiate Neutral
2025-11-25HC Wainwright & Co.Reiterate Buy -> Buy
2025-11-18Wolfe ResearchInitiate Peer Perform
2025-10-20HC Wainwright & Co.Reiterate Buy -> Buy
2025-10-10HC Wainwright & Co.Reiterate Buy -> Buy
2025-09-25Canaccord GenuityMaintains Buy -> Buy
2025-09-10Canaccord GenuityMaintains Buy -> Buy
2025-08-01Canaccord GenuityMaintains Buy -> Buy
2025-08-01Piper SandlerMaintains Overweight -> Overweight
2025-05-06HC Wainwright & Co.Maintains Buy -> Buy
2025-04-03Piper SandlerMaintains Overweight -> Overweight
2025-04-01Canaccord GenuityMaintains Buy -> Buy
2025-03-31Truist SecuritiesMaintains Buy -> Buy
2025-03-31HC Wainwright & Co.Maintains Buy -> Buy
2025-02-27Piper SandlerMaintains Overweight -> Overweight
2025-02-27HC Wainwright & Co.Reiterate Buy -> Buy
2025-02-11HC Wainwright & Co.Maintains Buy -> Buy
2025-02-07HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-30Canaccord GenuityMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$0.02
Revenue Estimate
196.36M
Revenue Q2Q
24.90%
EPS Q2Q
-88.00%
Number of Analysts
8

Next Earnings Revisions

Revenue (1 Month)
-8.11%
Revenue (3 Months)
-19.16%
EPS (1 Month)
123.26%
EPS (3 Months)
129.63%

Next Earnings Summary

CORT is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is 0.02 USD and the consensus revenue estimate is 196.36M USD.
The next earnings revenue estimate has been revised downward by 19.16% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CORT revenue by date.CORT revenue by date.
482.375M
20.02%		675.04M
39.94%		761.407M
12.79%		989.61M
29.97%		1.289B
30.25%		1.564B
21.33%		1.916B
22.51%		2.281B
19.05%		2.465B
8.07%		2.646B
7.34%		2.756B
4.16%
EBITDA
YoY % growth
CORT ebitda by date.CORT ebitda by date.
108.324M
-4.48%		137.746M
27.16%		45.946M
-66.64%		191.98M
317.84%		170.69M
-11.09%		438.83M
157.09%		413.41M
-5.79%		460.63M
11.42%		N/AN/AN/A
EBIT
YoY % growth
CORT ebit by date.CORT ebit by date.
107.282M
-4.72%		136.951M
27.66%		44.797M
-67.29%		133.93M
198.97%		510.47M
281.15%		1.128B
120.97%		956.19M
-15.23%		1.329B
38.99%		1.564B
17.68%		1.692B
8.18%		1.762B
4.14%
Operating Margin
CORT operating margin by date.CORT operating margin by date.
22.24%20.29%5.88%13.53%39.60%72.12%49.91%58.26%63.45%63.95%63.93%
EPS
YoY % growth
CORT eps by date.CORT eps by date.
0.95
7.95%		1.24
30.53%		0.82
-33.87%		0.83
0.76%		2.24
171.11%		4.39
96.04%		6.25
42.39%		8.57
37.08%		9.68
12.93%		10.45
7.96%		10.86
3.95%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		0.02
-88.00%		0.13
-53.57%		0.13
-17.13%		0.79
293.72%
Revenue
Q2Q % growth		196.36M
24.90%		230.69M
18.65%		277M
33.41%		390.22M
93.06%
EBITDA
Q2Q % growth		31.273M
744.99%		32.722M
20.10%		85.986M
676.12%		109.41M
1,841.27%
EBIT
Q2Q % growth		-1.278M
-137.41%		15.836M
-40.63%		38.046M
272.31%		142.3M
3,071.38%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CORT Yearly Revenue VS EstimatesCORT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B 2.5B
CORT Yearly EPS VS EstimatesCORT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 4 6 8 10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
74.95%
EPS Next 5 Year
59.90%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
23.49%
Revenue Next 5 Year
22.39%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
69.77%
EBIT Next 5 Year
38.71%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CORCEPT THERAPEUTICS INC / CORT Forecast FAQ

What is the price target for CORT stock?

12 analysts have analysed CORT and the average price target is 85.68 USD. This implies a price increase of 166.5% is expected in the next year compared to the current price of 32.15.

Can you provide the upcoming earnings date for CORCEPT THERAPEUTICS INC?

CORCEPT THERAPEUTICS INC (CORT) will report earnings on 2026-05-04.

Can you provide the consensus estimates for CORCEPT THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of CORCEPT THERAPEUTICS INC (CORT) is 0.02 USD and the consensus revenue estimate is 196.36M USD.

How many analysts have analysed CORCEPT THERAPEUTICS INC (CORT)?

The number of analysts covering CORCEPT THERAPEUTICS INC (CORT) is 12.